Loading...

Eric S Daar

Title(s)Professor of Clinical , Medicine
SchoolMedicine
Address760 Westwood Plaza 12-138
Los Angeles CA 90024
Phone(310) 222-2467
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Measuring and Monitoring Adherence to ART with Pill Ingestion Sensor System
    NIH/NIMH R01MH110056Sep 23, 2015 - Jul 31, 2020
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Efavirenz Pharmacogenetics and Weight Gain following Switch to Integrase Inhibitor-containing Regimens. Clin Infect Dis. 2020 Aug 23. Leonard MA, Cindi Z, Bradford Y, Bourgi K, Koethe J, Turner M, Norwood J, Woodward B, Erdem H, Basham R, Baker P, Rebeiro PF, Sterling TR, Hulgan T, Daar ES, Gulick R, Riddler SA, Sinxadi P, Ritchie MD, Haas DW. PMID: 32829410.
      View in: PubMed   Mentions:    Fields:    
    2. Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. J Infect Dis. 2020 Jul 09; 222(Supplement_1):S63-S69. Neilan TG, Nguyen KL, Zaha VG, Chew KW, Morrison L, Ntusi NAB, Toribio M, Awadalla M, Drobni ZD, Nelson MD, Burdo TH, Van Schalkwyk M, Sax PE, Skiest DJ, Tashima K, Landovitz RJ, Daar E, Wurcel AG, Robbins GK, Bolan RK, Fitch KV, Currier JS, Bloomfield GS, Desvigne-Nickens P, Douglas PS, Hoffmann U, Grinspoon SK, Ribaudo H, Dawson R, Goetz MB, Jain MK, Warner A, Szczepaniak LS, Zanni MV. PMID: 32645158.
      View in: PubMed   Mentions:    Fields:    
    3. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature. 2020 08; 584(7822):614-618. Link JO, Rhee MS, Tse WC, Zheng J, Somoza JR, Rowe W, Begley R, Chiu A, Mulato A, Hansen D, Singer E, Tsai LK, Bam RA, Chou CH, Canales E, Brizgys G, Zhang JR, Li J, Graupe M, Morganelli P, Liu Q, Wu Q, Halcomb RL, Saito RD, Schroeder SD, Lazerwith SE, Bondy S, Jin D, Hung M, Novikov N, Liu X, Villaseñor AG, Cannizzaro CE, Hu EY, Anderson RL, Appleby TC, Lu B, Mwangi J, Liclican A, Niedziela-Majka A, Papalia GA, Wong MH, Leavitt SA, Xu Y, Koditek D, Stepan GJ, Yu H, Pagratis N, Clancy S, Ahmadyar S, Cai TZ, Sellers S, Wolckenhauer SA, Ling J, Callebaut C, Margot N, Ram RR, Liu YP, Hyland R, Sinclair GI, Ruane PJ, Crofoot GE, McDonald CK, Brainard DM, Lad L, Swaminathan S, Sundquist WI, Sakowicz R, Chester AE, Lee WE, Daar ES, Yant SR, Cihlar T. PMID: 32612233.
      View in: PubMed   Mentions: 2     Fields:    
    4. Initiation of Antiretroviral Therapy in the Hospital is Associated with Linkage to HIV Care for Persons Living with HIV and Substance Use. Clin Infect Dis. 2020 Jun 22. Jacobs P, Feaster DJ, Pan Y, Gooden L, Daar ES, Lucas G, Jain MK, Marsh E, Armstrong WS, Rodriguez A, Del Rio C, Metsch LR. PMID: 32569355.
      View in: PubMed   Mentions:    Fields:    
    5. Perceptions of People Living with HIV and HIV Healthcare Providers on Real-Time Measuring and Monitoring of Antiretroviral Adherence Using Ingestible Sensors: A Qualitative Study. AIDS Res Treat. 2020; 2020:1098109. Kamal S, Rosen MI, Lazar C, Siqueiros L, Wang Y, Daar ES, Liu H. PMID: 32566285.
      View in: PubMed   Mentions:
    6. Pharmacokinetics of Coencapsulated Antiretrovirals with Ingestible Sensors. AIDS Res Hum Retroviruses. 2020 01; 36(1):65-74. Liu H, Daar E, Wang Y, Siqueiros L, Campbell K, Shen J, Guerrero M, Ko MW, Xiong D, Dao J, Young T, Rosen M, Fletcher CV. PMID: 31516025.
      View in: PubMed   Mentions: 1     Fields:    
    7. Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot Study. Clin Transl Sci. 2020 01; 13(1):189-194. Daar ES, Rosen MI, Wang Y, Siqueiros L, Shen J, Guerrero M, Xiong D, Dao J, Young T, Corado K, Fletcher CV, Liu H. PMID: 31536156.
      View in: PubMed   Mentions: 2     Fields:    
    8. Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV. Int J STD AIDS. 2019 08; 30(9):891-901. Pan Y, Metsch LR, Gooden LK, Philbin MM, Daar ES, Douaihy A, Jacobs P, Del Rio C, Rodriguez AE, Feaster DJ. PMID: 31159715.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2019 05 17; 68(11):1877-1886. Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. PMID: 30219823.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    10. Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202. Antimicrob Agents Chemother. 2019 04; 63(4). Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Acosta EP, Mager DE, Morse GD. PMID: 30642925.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    11. Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral Therapy. . 2019 03 01; 80(3):358-366. Hulgan T, Ramsey BS, Koethe JR, Samuels DC, Gerschenson M, Libutti DE, Sax PE, Daar ES, McComsey GA, Brown TT. PMID: 30531304.
      View in: PubMed   Mentions:
    12. Progressive brain atrophy in chronically infected and treated HIV+ individuals. J Neurovirol. 2019 06; 25(3):342-353. Nir TM, Jahanshad N, Ching CRK, Cohen RA, Harezlak J, Schifitto G, Lam HY, Hua X, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Singer EJ, Alger JR, Thompson PM, Navia BA. PMID: 30767174.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    13. Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV. . 2019 01 01; 80(1):e9-e13. Milam J, Jain S, Dubé MP, Daar ES, Sun X, Corado K, Ellorin E, Blumenthal J, Haubrich R, Moore DJ, Morris SR. PMID: 30334877.
      View in: PubMed   Mentions:
    14. The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized Human Immunodeficiency Virus-Infected Patients in 11 US Cities. Clin Infect Dis. 2019 01 01; 68(1):146-149. Philbin MM, Feaster DJ, Gooden L, Duan R, Das M, Jacobs P, Lucas GM, Batey DS, Nijhawan A, Jacobson JM, Mandler R, Daar E, McMahon DK, Armstrong WS, Del Rio C, Metsch LR. PMID: 29920584.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    15. Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy. Drug Des Devel Ther. 2018; 12:3731-3740. Corado KC, Caplan MR, Daar ES. PMID: 30464404.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    16. Antiretroviral switch studies do matter. Lancet HIV. 2018 10; 5(10):e546. Daar ES, Ruane P, DeJesus E, Stellbrink HJ, Molina JM. PMID: 30319119.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex With Men. J Infect Dis. 2018 10 05; 218(10):1551-1559. Pasipanodya EC, Jain S, Sun X, Blumenthal J, Ellorin E, Corado K, Dube MP, Daar ES, Morris SR, Moore DJ. PMID: 30295803.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    18. Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood. J Clin Pharmacol. 2018 12; 58(12):1604-1617. Yang J, Nikanjam M, Best BM, Pinto J, Chadwick EG, Daar ES, Havens PL, Rakhmanina N, Capparelli EV. PMID: 30252146.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. CD8+ Cytotoxic T Lymphocyte Responses and Viral Epitope Escape in Acute HIV-1 Infection. Viral Immunol. 2018 09; 31(7):525-536. Kim J, De La Cruz J, Lam K, Ng H, Daar ES, Balamurugan A, Yang OO. PMID: 30059271.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    20. Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics. 2018 07; 28(7):179-187. Haas DW, Bradford Y, Verma A, Verma SS, Eron JJ, Gulick RM, Riddler SA, Sax PE, Daar ES, Morse GD, Acosta EP, Ritchie MD. PMID: 29847509.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    21. Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2018 07; 5(7):e347-e356. Daar ES, DeJesus E, Ruane P, Crofoot G, Oguchi G, Creticos C, Rockstroh JK, Molina JM, Koenig E, Liu YP, Custodio J, Andreatta K, Graham H, Cheng A, Martin H, Quirk E. PMID: 29925490.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    22. Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav. 2018 Jun; 22(6):2026-2032. Winhusen T, Feaster DJ, Duan R, Brown JL, Daar ES, Mandler R, Metsch LR. PMID: 29030717.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    23. Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis. 2018 05 02; 66(10):1566-1572. Moore DJ, Jain S, Dubé MP, Daar ES, Sun X, Young J, Corado K, Ellorin E, Milam J, Collins D, Blumenthal J, Best BM, Anderson P, Haubrich R, Morris SR. PMID: 29228144.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    24. Next generation fixed dose combination pharmacotherapies for treating HIV. Expert Opin Pharmacother. 2018 04; 19(6):589-596. Caplan MR, Daar ES, Corado KC. PMID: 29557204.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    25. Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights. J R Stat Soc Ser A Stat Soc. 2018 Oct; 181(4):1193-1209. Buchanan AL, Hudgens MG, Cole SR, Mollan KR, Sax PE, Daar ES, Adimora AA, Eron JJ, Mugavero MJ. PMID: 30555215.
      View in: PubMed   Mentions:
    26. Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants. Ther Drug Monit. 2017 12; 39(6):596-603. Bednasz CJ, Venuto CS, Ma Q, Daar ES, Sax PE, Fischl MA, Collier AC, Smith KY, Tierney C, Yang Y, Wilding GE, Morse GD. PMID: 29135907.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    27. Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants. J Infect Dis. 2017 09 01; 216(5):554-564. Mollan KR, Tierney C, Hellwege JN, Eron JJ, Hudgens MG, Gulick RM, Haubrich R, Sax PE, Campbell TB, Daar ES, Robertson KR, Ventura D, Ma Q, Edwards DRV, Haas DW. PMID: 28931220.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial. Lancet. 2017 Nov 04; 390(10107):2063-2072. Gallant J, Lazzarin A, Mills A, Orkin C, Podzamczer D, Tebas P, Girard PM, Brar I, Daar ES, Wohl D, Rockstroh J, Wei X, Custodio J, White K, Martin H, Cheng A, Quirk E. PMID: 28867497.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    29. Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study. Clin Infect Dis. 2017 Jul 01; 65(1):6-12. Wyles D, Bräu N, Kottilil S, Daar ES, Ruane P, Workowski K, Luetkemeyer A, Adeyemi O, Kim AY, Doehle B, Huang KC, Mogalian E, Osinusi A, McNally J, Brainard DM, McHutchison JG, Naggie S, Sulkowski M. PMID: 28369210.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    30. Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study. Clin Infect Dis. 2017 Jun 01; 64(11):1612-1614. Parker RA, Rabideau DJ, Sax PE, Tierney C, Daar ES, Collier AC, Losina E, Freedberg KA. PMID: 28329243.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    31. Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. . 2017 06 01; 75(2):226-231. Raffi F, Orkin C, Clarke A, Slama L, Gallant J, Daar E, Henry K, Santana-Bagur J, Stein DK, Bellos N, Scarsella A, Yan M, Abram ME, Cheng A, Rhee MS. PMID: 28272164.
      View in: PubMed   Mentions:
    32. Novel approaches to HIV therapy. F1000Res. 2017; 6:759. Daar ES. PMID: 28649373.
      View in: PubMed   Mentions:    Fields:    
    33. Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202. Pharmacogenet Genomics. 2017 03; 27(3):101-111. Verma A, Bradford Y, Verma SS, Pendergrass SA, Daar ES, Venuto C, Morse GD, Ritchie MD, Haas DW. PMID: 28099408.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    34. Emtricitabine + tenofovir alafenamide for the treatment of HIV. Expert Opin Pharmacother. 2017 Mar; 18(4):427-432. Corado KC, Daar ES. PMID: 28151023.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    35. HIV viral kinetics and T cell dynamics in antiretroviral naïve persons starting an integrase strand transfer inhibitor and protease inhibitor regimen. HIV Clin Trials. 2017 03; 18(2):67-74. Karris MY, Jain S, Day TR, Pérez-Santiago J, Goicoechea M, Dubé MP, Sun X, Spina C, Daar ES, Haubrich RH, Morris S. PMID: 28134057.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    36. Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. JAMA. 2016 Jul 12; 316(2):156-70. Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C. PMID: 27404184.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    37. Condomless Sex With Virologically Suppressed HIV-Infected Individuals: How Safe Is It? JAMA. 2016 Jul 12; 316(2):149-51. Daar ES, Corado K. PMID: 27404181.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Brief Report: Effect of CMV and HIV Transcription on CD57 and PD-1 T-Cell Expression During Suppressive ART. . 2016 06 01; 72(2):133-7. Dan JM, Massanella M, Smith DM, Spina CA, Schrier R, Daar ES, Dube MP, Morris SR, Gianella S. PMID: 26818740.
      View in: PubMed   Mentions:
    39. Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue. . 2016 06 01; 72(2):e48-50. Karris MY, Jain S, Bowman VQ, Rieg G, Goicoechea M, Dube MP, Kerkar S, Kemper C, Diamond C, Sun X, Daar ES, Haubrich RH, Morris S. PMID: 26977746.
      View in: PubMed   Mentions:
    40. Randomized Controlled Trial of an Internet Application to Reduce HIV Transmission Behavior Among HIV Infected Men Who have Sex with Men. AIDS Behav. 2016 06; 20(6):1173-1181. Milam J, Morris S, Jain S, Sun X, Dubé MP, Daar ES, Jimenez G, Haubrich R. PMID: 26487300.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials. Clin Infect Dis. 2016 07 15; 63(2):268-80. Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD. PMID: 27090986.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial. Lancet HIV. 2016 Apr; 3(4):e158-65. Gallant JE, Daar ES, Raffi F, Brinson C, Ruane P, DeJesus E, Johnson M, Clumeck N, Osiyemi O, Ward D, Morales-Ramirez J, Yan M, Abram ME, Plummer A, Cheng AK, Rhee MS. PMID: 27036991.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCellsCTClinical Trials
    43. Implementation and Operational Research: The Navigation Program: An Intervention to Reengage Lost Patients at 7 HIV Clinics in Los Angeles County, 2012-2014. . 2016 Feb 01; 71(2):e44-50. Wohl AR, Dierst-Davies R, Victoroff A, James S, Bendetson J, Bailey J, Daar E, Spencer L, Kulkarni S, Pérez MJ. PMID: 26484741.
      View in: PubMed   Mentions:
    44. Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy. BMC Infect Dis. 2016 Jan 25; 16:24. Gianella S, Ginocchio CC, Daar ES, Dube MP, Morris SR. PMID: 26809559.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    45. Distinct cytokine/chemokine network in semen and blood characterize different stages of HIV infection. AIDS. 2016 Jan; 30(2):193-201. Vanpouille C, Introini A, Morris SR, Margolis L, Daar ES, Dube MP, Little SJ, Smith DM, Lisco A, Gianella S. PMID: 26558730.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    46. Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. Pharmacogenet Genomics. 2015 Sep; 25(9):450-61. Wanga V, Venuto C, Morse GD, Acosta EP, Daar ES, Haas DW, Li C, Shepherd BE. PMID: 26148204.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    47. Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy. Sci Rep. 2015 Aug 24; 5:13179. Massanella M, Gianella S, Schrier R, Dan JM, Pérez-Santiago J, Oliveira MF, Richman DD, Little SJ, Benson CA, Daar ES, Dube MP, Haubrich RH, Smith DM, Morris SR. PMID: 26299251.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    48. Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men. PLoS One. 2015; 10(6):e0130410. Gianella S, Smith DM, Daar ES, Dube MP, Lisco A, Vanpouille C, Margolis L, Haubrich RH, Morris SR. PMID: 26061824.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    49. Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s. . 2015 Jun 01; 69(2):168-77. Longenecker CT, Kitch D, Sax PE, Daar ES, Tierney C, Gupta SK, McComsey GA. PMID: 26009829.
      View in: PubMed   Mentions:
    50. A Remotely-Delivered CBT and Contingency Management Therapy for Substance Using People with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:156-62. Moore BA, Rosen MI, Wang Y, Shen J, Ablondi K, Sullivan A, Guerrero M, Siqueiros L, Daar ES, Liu H. PMID: 25645326.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    51. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy. . 2015 May 01; 69(1):29-35. Anderson AM, Harezlak J, Bharti A, Mi D, Taylor MJ, Daar ES, Schifitto G, Zhong J, Alger JR, Brown MS, Singer EJ, Campbell TB, McMahon DD, Buchthal S, Cohen R, Yiannoutsos C, Letendre SL, Navia BA. PMID: 25622053.
      View in: PubMed   Mentions:
    52. Genome-wide association study of virologic response with efavirenz-containing or abacavir-containing regimens in AIDS clinical trials group protocols. Pharmacogenet Genomics. 2015 Feb; 25(2):51-9. Lehmann DS, Ribaudo HJ, Daar ES, Gulick RM, Haubrich RH, Robbins GK, de Bakker PI, Haas DW, McLaren PJ. PMID: 25461247.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    53. Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine. . 2014 Sep 01; 67(1):36-44. Wyatt CM, Kitch D, Gupta SK, Tierney C, Daar ES, Sax PE, Ha B, Melbourne K, McComsey GA. PMID: 25117929.
      View in: PubMed   Mentions:
    54. Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202. J Antimicrob Chemother. 2014 Dec; 69(12):3300-10. Venuto CS, Mollan K, Ma Q, Daar ES, Sax PE, Fischl M, Collier AC, Smith KY, Tierney C, Morse GD. PMID: 25159623.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Short communication: HIV-1 gag genetic variation in a single acutely infected participant defined by high-resolution deep sequencing. AIDS Res Hum Retroviruses. 2014 Aug; 30(8):806-11. Al-Mawsawi LQ, Wu NC, De La Cruz J, Shi VC, Wu TT, Daar ES, Lewis MJ, Yang OO, Sun R. PMID: 24914638.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    56. Antiretroviral therapy: treatment-experienced individuals. Infect Dis Clin North Am. 2014 Sep; 28(3):439-56. Calvo KR, Daar ES. PMID: 25151565.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    57. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann Intern Med. 2014 Jul 01; 161(1):1-10. Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, Gulick RM, Na L, O'Keefe L, Robertson KR, Tierney C. PMID: 24979445.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    58. Impaired Nef function is associated with early control of HIV-1 viremia. J Virol. 2014 Sep 01; 88(17):10200-13. Kuang XT, Li X, Anmole G, Mwimanzi P, Shahid A, Le AQ, Chong L, Qian H, Miura T, Markle T, Baraki B, Connick E, Daar ES, Jessen H, Kelleher AD, Little S, Markowitz M, Pereyra F, Rosenberg ES, Walker BD, Ueno T, Brumme ZL, Brockman MA. PMID: 24965469.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    59. Impact of randomized antiretroviral therapy initiation on glucose metabolism. AIDS. 2014 Jun 19; 28(10):1451-61. Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Melbourne KM, Ha B, McComsey GA. PMID: 24637543.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    60. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15; 59(6):888-96. Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. PMID: 24842909.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    61. Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J Virol. 2014 Jul; 88(14):7818-27. Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM. PMID: 24789781.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    62. Ineffectual targeting of HIV-1 Nef by cytotoxic T lymphocytes in acute infection results in no functional impairment or viremia reduction. J Virol. 2014 Jul; 88(14):7881-92. De La Cruz J, Vollbrecht T, Frohnen P, Ng HL, Daar ES, Yang OO, Lewis MJ. PMID: 24789790.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    63. Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial. Open Forum Infect Dis. 2014 Mar; 1(1):ofu003. Gupta SK, Kitch D, Tierney C, Daar ES, Sax PE, Melbourne K, Ha B, McComsey GA. PMID: 25734077.
      View in: PubMed   Mentions:
    64. Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202. Pharmacogenet Genomics. 2014 Apr; 24(4):195-203. Johnson DH, Venuto C, Ritchie MD, Morse GD, Daar ES, McLaren PJ, Haas DW. PMID: 24557078.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    65. Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202. . 2014 Feb 01; 65(2):167-74. McComsey GA, Kitch D, Sax PE, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Daar ES. PMID: 24121755.
      View in: PubMed   Mentions:
    66. Factors associated with high transmission risk and detectable plasma HIV RNA in HIV-infected MSM on ART. Int J STD AIDS. 2014 Sep; 25(10):734-41. Blumenthal J, Haubrich R, Jain S, Sun X, Dube M, Daar E, Milam J, Morris S. PMID: 24452730.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    67. Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine. PLoS One. 2013; 8(12):e83514. Funderburg NT, Andrade A, Chan ES, Rosenkranz SL, Lu D, Clagett B, Pilch-Cooper HA, Rodriguez B, Feinberg J, Daar E, Mellors J, Kuritzkes D, Jacobson JM, Lederman MM. PMID: 24367599.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCellsCTClinical Trials
    68. Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine. Clin Infect Dis. 2014 Feb; 58(4):555-63. Smith KY, Tierney C, Mollan K, Venuto CS, Budhathoki C, Ma Q, Morse GD, Sax P, Katzenstein D, Godfrey C, Fischl M, Daar ES, Collier AC. PMID: 24253247.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    69. Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment. AIDS. 2013 Nov 13; 27(17):2725-34. Hua L, Andersen JW, Daar ES, Glesby MJ, Hollabaugh K, Tierney C. PMID: 23921611.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202. HIV Clin Trials. 2013 Nov-Dec; 14(6):284-91. Grant PM, Tierney C, Budhathoki C, Daar ES, Sax PE, Collier AC, Fischl MA, Zolopa AR, Balamane M, Katzenstein D. PMID: 24334181.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    71. Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density. AIDS. 2013 Aug 24; 27(13):2069-79. Erlandson KM, Kitch D, Tierney C, Sax PE, Daar ES, Tebas P, Melbourne K, Ha B, Jahed NC, McComsey GA. PMID: 24384588.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    72. Virologic correlates of anti-CMV IgG levels in HIV-1-infected men. J Infect Dis. 2014 Feb 01; 209(3):452-6. Gianella S, Morris SR, Tatro E, Vargas MV, Haubrich RH, Daar ES, Dube MP, Richman DD, Little SJ, Smith DM. PMID: 23964106.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    73. Limited nucleotide changes in the Rev response element (RRE) during HIV-1 infection alter overall Rev-RRE activity and Rev multimerization. J Virol. 2013 Oct; 87(20):11173-86. Sloan EA, Kearney MF, Gray LR, Anastos K, Daar ES, Margolick J, Maldarelli F, Hammarskjold ML, Rekosh D. PMID: 23926352.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    74. Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatment. Neuroimage Clin. 2013; 3:132-42. Hua X, Boyle CP, Harezlak J, Tate DF, Yiannoutsos CT, Cohen R, Schifitto G, Gongvatana A, Zhong J, Zhu T, Taylor MJ, Campbell TB, Daar ES, Alger JR, Singer E, Buchthal S, Toga AW, Navia B, Thompson PM. PMID: 24179857.
      View in: PubMed   Mentions: 32     Fields:    
    75. Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248. J Infect Dis. 2013 Sep; 208(6):884-91. Andrade A, Rosenkranz SL, Cillo AR, Lu D, Daar ES, Jacobson JM, Lederman M, Acosta EP, Campbell T, Feinberg J, Flexner C, Mellors JW, Kuritzkes DR. PMID: 23801609.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCellsCTClinical Trials
    76. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. J Neurovirol. 2013 Jun; 19(3):209-18. Gongvatana A, Harezlak J, Buchthal S, Daar E, Schifitto G, Campbell T, Taylor M, Singer E, Algers J, Zhong J, Brown M, McMahon D, So YT, Mi D, Heaton R, Robertson K, Yiannoutsos C, Cohen RA, Navia B. PMID: 23613008.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    77. Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men. Clin Infect Dis. 2013 Aug; 57(3):441-7. Gianella S, Smith DM, Vargas MV, Little SJ, Richman DD, Daar ES, Dube MP, Zhang F, Ginocchio CC, Haubrich RH, Morris SR. PMID: 23595831.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    78. Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease. Antivir Ther. 2013; 18(3):399-408. Schackman BR, Haas DW, Becker JE, Berkowitz BK, Sax PE, Daar ES, Ribaudo HJ, Freedberg KA. PMID: 23264445.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    79. Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants. Pharmacogenet Genomics. 2012 Dec; 22(12):858-67. Holzinger ER, Grady B, Ritchie MD, Ribaudo HJ, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford DB, Daar ES, McLaren P, Haas DW. PMID: 23080225.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    80. Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202. J Infect Dis. 2013 Feb 15; 207(4):604-11. McComsey GA, Daar ES, O'Riordan M, Collier AC, Kosmiski L, Santana JL, Fichtenbaum CJ, Fink H, Sax PE, Libutti DE, Gerschenson M. PMID: 23204164.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    81. HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status. J Infect Dis. 2012 Dec 15; 206(12):1920-30. Mollan K, Daar ES, Sax PE, Balamane M, Collier AC, Fischl MA, Lalama CM, Bosch RJ, Tierney C, Katzenstein D. PMID: 23148287.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    82. Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202. J Infect Dis. 2013 Feb 01; 207(3):420-5. Ribaudo HJ, Daar ES, Tierney C, Morse GD, Mollan K, Sax PE, Fischl MA, Collier AC, Haas DW. PMID: 23148286.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    83. Role of GB virus C in HIV-1-infected and hepatitis C virus-infected hemophiliac children and adolescents. . 2012 Oct 01; 61(2):243-8. Tenckhoff S, Kaiser T, Bredeek F, Donfield S, Menius E, Lail A, Mössner J, Daar ES, Tillmann HL. PMID: 23007118.
      View in: PubMed   Mentions:
    84. Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS. 2012 Jul 17; 26(11):1371-85. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Melbourne K, Ha B, Brown TT, Bloom A, Fedarko N, Sax PE. PMID: 22546988.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    85. The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis. 2012 Jan 01; 205(1):87-96. Hogan CM, Degruttola V, Sun X, Fiscus SA, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima KT, Kallungal B, Camp R, Morton T, Daar ES, Little S. PMID: 22180621.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    86. Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results. J Infect Dis. 2011 Oct 15; 204(8):1191-201. Sax PE, Tierney C, Collier AC, Daar ES, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Feinberg J, Tashima K, Murphy RL, Fischl MA. PMID: 21917892.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCellsCTClinical Trials
    87. Barriers and unmet need for supportive services for HIV patients in care in Los Angeles County, California. AIDS Patient Care STDS. 2011 Sep; 25(9):525-32. Wohl AR, Carlos JA, Tejero J, Dierst-Davies R, Daar ES, Khanlou H, Cadden J, Towner W, Frye D. PMID: 21774689.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    88. Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s. Clin Infect Dis. 2011 Jul 15; 53(2):185-96. McComsey GA, Kitch D, Sax PE, Tebas P, Tierney C, Jahed NC, Myers L, Melbourne K, Ha B, Daar ES. PMID: 21690627.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    89. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. J Infect Dis. 2011 Jun 15; 203(12):1791-801. McComsey GA, Kitch D, Daar ES, Tierney C, Jahed NC, Tebas P, Myers L, Melbourne K, Ha B, Sax PE. PMID: 21606537.
      View in: PubMed   Mentions: 163     Fields:    Translation:Humans
    90. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies. J Neurovirol. 2011 Aug; 17(4):368-79. Tate DF, Sampat M, Harezlak J, Fiecas M, Hogan J, Dewey J, McCaffrey D, Branson D, Russell T, Conley J, Taylor M, Schifitto G, Schifitto G, Zhong J, Daar ES, Alger J, Brown M, Singer E, Campbell T, McMahon D, Tso Y, Matesan J, Letendre S, Paulose S, Gaugh M, Tripoli C, Yiannoutsos C, Bigler ED, Cohen RA, Guttmann CR, Navia B. PMID: 21556960.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    91. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS. 2011 Mar 13; 25(5):625-33. Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B. PMID: 21297425.
      View in: PubMed   Mentions: 161     Fields:    Translation:Humans
    92. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Ann Intern Med. 2011 Apr 05; 154(7):445-56. Daar ES, Tierney C, Fischl MA, Sax PE, Mollan K, Budhathoki C, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Pappa KA, Woodward WC, Patterson K, Bolivar H, Benson CA, Collier AC. PMID: 21320923.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansCells
    93. Behaviors of recently HIV-infected men who have sex with men in the year postdiagnosis: effects of drug use and partner types. . 2011 Feb 01; 56(2):176-82. Gorbach PM, Weiss RE, Jeffries R, Javanbakht M, Drumright LN, Daar ES, Little SJ. PMID: 21119524.
      View in: PubMed   Mentions:
    94. Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis. 2011 Feb 15; 203(4):442-51. Meditz AL, MaWhinney S, Allshouse A, Feser W, Markowitz M, Little S, Hecht R, Daar ES, Collier AC, Margolick J, Kilby JM, Routy JP, Conway B, Kaldor J, Levy J, Schooley R, Cooper DA, Altfeld M, Richman D, Connick E. PMID: 21245157.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    95. Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia. AIDS Res Hum Retroviruses. 2011 Apr; 27(4):391-8. Yang OO, Daar ES, Ng HL, Shih R, Jamieson BD. PMID: 21087140.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    96. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science. 2010 Dec 10; 330(6010):1551-7. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC, Olender SA, Ostrowski M, Owen WF, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M. PMID: 21051598.
      View in: PubMed   Mentions: 544     Fields:    Translation:HumansCells
    97. Impaired replication capacity of acute/early viruses in persons who become HIV controllers. J Virol. 2010 Aug; 84(15):7581-91. Miura T, Brumme ZL, Brockman MA, Rosato P, Sela J, Brumme CJ, Pereyra F, Kaufmann DE, Trocha A, Block BL, Daar ES, Connick E, Jessen H, Kelleher AD, Rosenberg E, Markowitz M, Schafer K, Vaida F, Iwamoto A, Little S, Walker BD. PMID: 20504921.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    98. Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200. . 2010 Apr 01; 53(4):491-5. Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertora J, Patterson KB, Daar ES, Cavert W, Brizz B. PMID: 20130470.
      View in: PubMed   Mentions:
    99. Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients. AIDS. 2010 Mar 13; 24(5):707-16. Goicoechea M, Jain S, Bi L, Kemper C, Daar ES, Diamond C, Ha B, Flaherty J, Sun S, Richman D, Louie S, Haubrich R. PMID: 20087154.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    100. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J Neurovirol. 2010 Feb; 16(1):25-32. Cohen RA, Harezlak J, Schifitto G, Hana G, Clark U, Gongvatana A, Paul R, Taylor M, Thompson P, Alger J, Brown M, Zhong J, Campbell T, Singer E, Daar E, McMahon D, Tso Y, Yiannoutsos CT, Navia B. PMID: 20113183.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    101. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. N Engl J Med. 2009 Dec 03; 361(23):2230-40. Sax PE, Tierney C, Collier AC, Fischl MA, Mollan K, Peeples L, Godfrey C, Jahed NC, Myers L, Katzenstein D, Farajallah A, Rooney JF, Ha B, Woodward WC, Koletar SL, Johnson VA, Geiseler PJ, Daar ES. PMID: 19952143.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    102. Newer antiretroviral agents and how to use them. Curr Infect Dis Rep. 2009 Jul; 11(4):327-34. Kim HH, Daar ES. PMID: 19545503.
      View in: PubMed   Mentions:
    103. Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapy. F1000 Med Rep. 2009 May 28; 1. Daar ES. PMID: 20948738.
      View in: PubMed   Mentions:
    104. Newer antiretroviral agents and how to use them. Curr HIV/AIDS Rep. 2009 May; 6(2):55-62. Kim HH, Daar ES. PMID: 19358775.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    105. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 2009 Apr 25; 387(1):98-108. Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. PMID: 19268337.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    106. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology. 2008 Dec; 48(6):1769-78. Kuntzen T, Timm J, Berical A, Lennon N, Berlin AM, Young SK, Lee B, Heckerman D, Carlson J, Reyor LL, Kleyman M, McMahon CM, Birch C, Schulze Zur Wiesch J, Ledlie T, Koehrsen M, Kodira C, Roberts AD, Lauer GM, Rosen HR, Bihl F, Cerny A, Spengler U, Liu Z, Kim AY, Xing Y, Schneidewind A, Madey MA, Fleckenstein JF, Park VM, Galagan JE, Nusbaum C, Walker BD, Lake-Bakaar GV, Daar ES, Jacobson IM, Gomperts ED, Edlin BR, Donfield SM, Chung RT, Talal AH, Marion T, Birren BW, Henn MR, Allen TM. PMID: 19026009.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansCells
    107. Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS Patient Care STDS. 2008 Dec; 22(12):947-54. Rieg G, Lewis RJ, Miller LG, Witt MD, Guerrero M, Daar ES. PMID: 19072101.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCellsPHPublic Health
    108. Emerging resistance profiles of newly approved antiretroviral drugs. Top HIV Med. 2008 Oct-Nov; 16(4):110-6. Daar ES. PMID: 18838744.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    109. Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance. AIDS. 2008 Apr 23; 22(7):835-9. Liu L, May S, Richman DD, Hecht FM, Markowitz M, Daar ES, Routy JP, Margolick JB, Collier AC, Woelk CH, Little SJ, Smith DM. PMID: 18427201.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    110. Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men. . 2008 Apr 15; 47(5):639-43. Gorbach PM, Drumright LN, Javanbakht M, Pond SL, Woelk CH, Daar ES, Little SJ. PMID: 18285715.
      View in: PubMed   Mentions:
    111. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection. Expert Opin Pharmacother. 2008 Apr; 9(5):687-700. Lagnese M, Daar ES. PMID: 18345948.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    112. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. J Virol. 2008 Mar; 82(6):2784-91. Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO. PMID: 18199650.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    113. Clinical presentation and diagnosis of primary HIV-1 infection. Curr Opin HIV AIDS. 2008 Jan; 3(1):10-5. Daar ES, Pilcher CD, Hecht FM. PMID: 19372938.
      View in: PubMed   Mentions: 17     Fields:    
    114. A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients. . 2007 Dec 01; 46(4):433-42. Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH. PMID: 17786128.
      View in: PubMed   Mentions:
    115. Platelet count is associated with plasma HIV type 1 RNA and disease progression. AIDS Res Hum Retroviruses. 2007 Oct; 23(10):1257-61. Rieg G, Yeaman M, Lail AE, Donfield SM, Gomperts ED, Daar ES. PMID: 17961113.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    116. Incorporating novel virologic tests into clinical practice. Top HIV Med. 2007 Aug-Sep; 15(4):126-9. Daar ES. PMID: 17720997.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    117. Baseline HIV type 1 coreceptor tropism predicts disease progression. Clin Infect Dis. 2007 Sep 01; 45(5):643-9. Daar ES, Kesler KL, Petropoulos CJ, Huang W, Bates M, Lail AE, Coakley EP, Gomperts ED, Donfield SM. PMID: 17683002.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    118. Hepatitis C virus and death risk in hemodialysis patients. J Am Soc Nephrol. 2007 May; 18(5):1584-93. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Miller LG, Daar ES, Gjertson DW, Kopple JD, Greenland S. PMID: 17429053.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    119. New approaches and resolve may define the future of the global HIV pandemic. Res Initiat Treat Action. 2007; 12(2):8-10. Daar ES. PMID: 17486706.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. Epidemiologic investigation of a cluster of workplace HIV infections in the adult film industry: Los Angeles, California, 2004. Clin Infect Dis. 2007 Jan 15; 44(2):301-5. Taylor MM, Rotblatt H, Brooks JT, Montoya J, Aynalem G, Smith L, Kenney K, Laubacher L, Bustamante T, Kim-Farley R, Fielding J, Bernard B, Daar E, Kerndt PR. PMID: 17173235.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    121. Measuring below the bar: what is it telling us? AIDS. 2006 Nov 28; 20(18):2385-7. Daar ES. PMID: 17117026.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    122. Novel antiretroviral agents in HIV therapy. Curr Infect Dis Rep. 2006 Nov; 8(6):489-96. Reed C, Daar ES. PMID: 17064643.
      View in: PubMed   Mentions:
    123. Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity. AIDS. 2006 Oct 24; 20(16):2123-5. Barbour JD, Hecht FM, Little SJ, Markowitz M, Daar ES, Kelleher AD, Routy JP, Campbell TB, Rosenberg ES, Segal MR, Weidler J, Grant RM. PMID: 17053362.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    124. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 2006 Nov 10; 355(1):1-5. Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD. PMID: 16962152.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    125. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis. 2006 Sep 15; 194(6):725-33. Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S. PMID: 16941337.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    126. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006 Jun 12; 20(9):1295-302. Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, Diamond C, Tilles JG, Kemper CA, Larsen R, Goicoechea M, Haubrich RH. PMID: 16816559.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    127. Transmission behaviors of recently HIV-infected men who have sex with men. . 2006 May; 42(1):80-5. Gorbach PM, Drumright LN, Daar ES, Little SJ. PMID: 16763494.
      View in: PubMed   Mentions:
    128. Molecular analysis of HIV strains from a cluster of worker infections in the adult film industry, Los Angeles 2004. AIDS. 2006 Apr 04; 20(6):923-8. Brooks JT, Robbins KE, Youngpairoj AS, Rotblatt H, Kerndt PR, Taylor MM, Daar ES, Kalish ML. PMID: 16549978.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    129. Human immunodeficiency virus and fertility care: embarking on a path of knowledge and access. Fertil Steril. 2006 Feb; 85(2):298-300; discussion 301. Daar ES, Daar JF. PMID: 16595202.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    130. Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression. J Infect Dis. 2005 Nov 01; 192(9):1597-605. Daar ES, Lynn HS, Donfield SM, Lail A, O'Brien SJ, Huang W, Winkler CA. PMID: 16206074.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    131. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis. 2005 Aug; 46(2):290-300. Kalantar-Zadeh K, Miller LG, Daar ES. PMID: 16112048.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    132. Longitudinal analysis of CD8 T-cell responses to HIV and hepatitis C virus in a cohort of co-infected haemophiliacs. AIDS. 2005 Jul 22; 19(11):1135-43. Harcourt GC, Donfield S, Gomperts E, Daar ES, Goulder P, Phillips RE, Klenerman P. PMID: 15990566.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    133. HIV-1 pol replication capacity predicts disease progression. AIDS. 2005 Jun 10; 19(9):871-7. Daar ES, Kesler KL, Wrin T, Petropoulo CJ, Bates M, Lail A, Hellmann NS, Gomperts E, Donfield S. PMID: 15905667.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    134. Primary human immunodeficiency virus type 1 infection. Curr HIV/AIDS Rep. 2005 Jun; 2(2):55-60. Soogoor M, Daar ES. PMID: 16091249.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    135. Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance. AIDS Res Hum Retroviruses. 2005 May; 21(5):343-57. Daar ES, Richman DD. PMID: 15929696.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    136. Strategies for initiating combination antiretroviral therapy. AIDS Patient Care STDS. 2005 Apr; 19(4):224-38. Tapper ML, Daar ES, Piliero PJ, Smith K, Steinhart C. PMID: 15857194.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 01; 191(9):1410-8. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. PMID: 15809898.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    138. Primary HIV-1 Infection: Diagnosis, Pathogenesis, and Treatment. Curr Infect Dis Rep. 2005 Mar; 7(2):147-153. Soogoor M, Daar ES. PMID: 15727743.
      View in: PubMed   Mentions:
    139. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol. 2005 Jan; 79(2):860-8. Yang OO, Daar ES, Jamieson BD, Balamurugan A, Smith DM, Pitt JA, Petropoulos CJ, Richman DD, Little SJ, Brown AJ. PMID: 15613314.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    140. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis. 2005 Jan 01; 191(1):4-10. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES. PMID: 15592996.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    141. Incidence of HIV superinfection following primary infection. JAMA. 2004 Sep 08; 292(10):1177-8. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ. PMID: 15353529.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    142. What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2. AIDS Read. 2004 Sep; 14(9):487-98. Ruane PJ, Daar ES. PMID: 15457602.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    143. What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 1. AIDS Read. 2004 Aug; 14(8):421-6, 431-2, 434. Ruane PJ, Daar ES. PMID: 15338522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    144. Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol. 2004 Jul; 78(13):7279-83. Sagar M, Kirkegaard E, Long EM, Celum C, Buchbinder S, Daar ES, Overbaugh J. PMID: 15194805.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    145. Antiretroviral rounds. Putting resistance to work. AIDS Clin Care. 2004 Jul; 16(7):56, 60. Daar ES, Elion R. PMID: 15300926.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    146. Lack of effect of recombinant human growth hormone on the in vitro activities of antiretroviral drugs against human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2004 Jun; 48(6):2337-40. Wainberg MA, Brenner BG, Daar E, Gertner JM, Olivier C, Kenley S. PMID: 15155249.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    147. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. . 2004 Apr 01; 35(4):367-75. Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E. PMID: 15097153.
      View in: PubMed   Mentions:
    148. Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection. J Virol. 2004 Mar; 78(5):2242-6. Leigh Brown AJ, Frost SD, Good B, Daar ES, Simon V, Markowitz M, Collier AC, Connick E, Conway B, Margolick JB, Routy JP, Corbeil J, Hellmann NS, Richman DD, Little SJ. PMID: 14963120.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    149. Potency and durability of antiretroviral therapy. . 2003 Oct 01; 34 Suppl 2:S111-7. Daar ES. PMID: 14703939.
      View in: PubMed   Mentions:
    150. Antiretroviral resistance in clinical practice. J Int Assoc Physicians AIDS Care (Chic). 2003 Sep; 2 Suppl 1:S4-18. Daar ES. PMID: 14569655.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    151. Antiretroviral rounds. The when, why and how of switching. AIDS Clin Care. 2003 Jun; 15(6):58-9. Henry K, Daar ES. PMID: 12866482.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    152. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med. 2003 Feb 24; 163(4):457-60. Matetzky S, Domingo M, Kar S, Noc M, Shah PK, Kaul S, Daar E, Cercek B. PMID: 12588205.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    153. Improving adherence to antiretroviral therapy. AIDS Read. 2003 Feb; 13(2):81-2, 85-6, 88-90. Daar ES, Cohen C, Remien R, Sherer R, Smith K. PMID: 12645492.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    154. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis. 2003 Feb 15; 187(4):683-6. Leigh Brown AJ, Frost SD, Mathews WC, Dawson K, Hellmann NS, Daar ES, Richman DD, Little SJ. PMID: 12599087.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    155. Treatment of primary HIV infection. MedGenMed. 2002 Nov 15; 4(4):15. Daar ES. PMID: 12817211.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    156. Isolation and characterization of an infectious HIV type 1 molecular clone from a patient with primary infection. AIDS Res Hum Retroviruses. 2002 Oct 10; 18(15):1127-33. Takeuchi H, Suzuki Y, Tatsumi M, Hoshino H, Daar ES, Koyanagi Y. PMID: 12402946.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    157. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002 Aug 08; 347(6):385-94. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD. PMID: 12167680.
      View in: PubMed   Mentions: 283     Fields:    Translation:HumansCells
    158. Identifying and managing morphologic complications of HIV and HAART. AIDS Read. 2002 Mar; 12(3):114-9, 124-5. Currier J, Carpenter C, Daar E, Kotler D, Wanke C. PMID: 11966241.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Eric's Networks
    Concepts (448)
    Derived automatically from this person's publications.
    _
    Co-Authors (67)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _